McLaren in Flint is the first in the world to add Leo cancer care treatment technology

Flint. // Courtesy of McLaren Health Care” width=”800″ height=”500″ srcset=”https://cdn.dbusiness.com/wp-content/uploads/sites/33/2022/07/McLarenProton-800.jpg 800w, https://cdn.dbusiness.com/wp-content/uploads/sites/33/2022/07/McLarenProton-800-300×188.jpg 300w, https://cdn.dbusiness.com/wp-content/uploads/sites/33/2022/07/McLarenProton-800-768×480.jpg 768w, https://cdn.dbusiness.com/wp-content/uploads/sites/33/2022/07/McLarenProton-800-696×435.jpg 696w, https://cdn.dbusiness.com/wp-content/uploads/sites/33/2022/07/McLarenProton-800-672×420.jpg 672w, https://cdn.dbusiness.com/wp-content/uploads/sites/33/2022/07/McLarenProton-800-600×375.jpg 600w” sizes=”(max-width: 800px) 100vw, 800px”/>
Leo Cancer Care’s vertical proton therapy treatment will debut at the McLaren Proton Therapy Center in Flint. // Courtesy of McLaren Health Care

McLaren Proton Therapy Center, located in Flint and part of the Detroit Karmanos Cancer Institute in Detroit, says it will be the first in the world to offer proton therapy to patients using Leo Cancer Care’s vertical treatment technology.

Through the agreement, Leo Cancer Care will install two vertical units at the McLaren Proton Therapy Center, with the first patients expected to receive care through the treatment system within the next two years after receiving FDA clearance for the technology.

“McLaren and Karmanos are committed to providing world-class comprehensive cancer care in Genesee County,” said Chris Candela, President and CEO of McLaren Flint. “The goal of our innovative partnership with Leo Cancer Care is to provide greater access to proton therapy for patients in Michigan and around the world.”

The addition of Leo Cancer Care technology and the expansion of the McLaren Proton Therapy Center are part of a larger project to develop and improve McLaren Flint’s comprehensive cancer program.

“The goal of the collaboration between Leo Cancer Care and McLaren Proton Therapy Center is to bring proton therapy to more patients, and we know that proton therapy has clear benefits,” said Stephen Towe, CEO of Leo Cancer Care. “The McLaren Proton Therapy Center is well positioned to become the first to potentially treat patients with breakthrough Leo Cancer Care technology.”

Towe noted research highlighting that upright positioning results in less organ movement during treatment while creating better communication channels between patient and clinician.

Proton therapy delivers highly targeted doses of radiation to cancer cells while sparing healthy tissue, reducing side effects and yielding positive results. The advantages of administering radiation therapy to patients seated in an upright position include comfort and a better patient experience compared to lying on a table.

McLaren ordered two Marie units from Leo Cancer Care, both fitting into an area marked for a single conventional rotating gantry, where patients lay horizontally, in its existing proton center.

With the equipment taking up half the space and effectively half the cost of conventional radiotherapy units, the agreement has significant commercial and economic benefits for the healthcare provider.

“Once we saw the site, we explained that we could add a dividing wall in the middle of the room and place two of our treatment devices in the same space that they were going to have originally with a gantry. It effectively doubles patient throughput from the same impression,” says Towe.

Marie units are equipped with dual-energy diagnostic-grade computed tomography at the treatment isocenter to enable adaptive therapy that will improve reliability, reduce maintenance costs, and enable upright imaging.

“McLaren will realize a significant reduction in capital costs by implementing the Leo Cancer Care Vertical Positioning and Imaging System instead of our current three-stage, hundred-plus-ton rotary gantry solution,” said Daniel Medrano. , co-director of research and development for the McLaren Proton Therapy System.

The equipment does not currently have CE marking in the EU, nor FDA 510k clearance in the US, but Leo is in the process of obtaining these regulatory approvals, which will be in place prior to installation on site. of Flint.

Comments are closed.